Item 9 Labs Corp. (INLB)
Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries. The firm produces a wide spectrum of cannabis and related goods, such as raw flower, various concentrates, distillates, and necessary hardware. These cannabis and derived technologies and products are then supplied to consumers in Arizona via licensed retail dispensaries. Complementing its production activities, the company also develops and offers medical and adult-use cannabis dispensary franchises under its distinct Unity Rd brand. The main office for Item 9 Labs Corp. is found in Phoenix, Arizona.
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
Item 9 Labs Corp.
- Not computed yet: no FINRA short interest has been matched to this float.
- 3.6K
- 1.00
Float 524.14M · FMP free float
The cost to borrow INLB shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- No fails on record for 16–31 Oct 2026.
No price or settlement history available to chart.
FINRA publishes no off-exchange short volume for this symbol.
FINRA's weekly alternative trading system (dark pool) volume for INLB: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.